Tirzepatide is a combination medication, incorporating both GLP-1 and GIP classes, whereas Semaglutide contains only GLP-1
Our providers assess individual profiles to tailor the most suitable treatment plan according to your health objectives and insurance compatibility
Sealed with an imprinted safety seal for your protection
Positive changes A noticeable reduction in bodyweight Be more active and making healthier food choices With Morrisons Clinic, gain education on relationship with food As your dosage increases you should see changes in your weight and your lifestyle
How is microdosing different from the full weight loss program
Study Design and Participant Selection This exploratory secondary analysis was conducted within a randomized, placebo-controlled clinical trial involving adults aged 18 to 65 years with obesity, defined as a body mass index between 32 and 43 kg per square meter, and without diabetes mellitus